Westport, CT, Feb. 20, 2024 (GLOBE NEWSWIRE) — — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company, today announced that it has terminated a significant number of its employees and expects to substantially reduce business operations. About BioSig Technologies, Inc. BioSig Technologies is a medical […]
Author: Ken Dropiewski
Stereotaxis to Report Fourth Quarter and Full Year 2023 Financial Results on March 4, 2024
ST. LOUIS, Feb. 20, 2024 (GLOBE NEWSWIRE) — Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for minimally invasive endovascular intervention, today announced that it will release financial results for its 2023 fourth quarter and full year ended December 31, 2023 on Monday, March 4, 2024 at […]
Reprieve Cardiovascular Emerges from Stealth Mode after $42 Million Series A Financing to Bring Intelligent Fluid Management to Heart Failure Patients
MILFORD, Mass.–(BUSINESS WIRE)–Reprieve Cardiovascular, Inc., a development stage company focused on pioneering an intelligent automated diuretic and fluid management approach for acute decompensated heart failure (ADHF) treatment, today announced it has raised a total of $42 million in series A financing. The total round was co-led by Lightstone Ventures and […]
Medtronic reports third quarter fiscal 2024 financial results
Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business returns to growth; Raises full year guidance DUBLIN, Feb. 20, 2024 /PRNewswire/ –…
AngioDynamics Announces Sale of PICC and Midline Product Portfolios to Spectrum Vascular for $45 Million
LATHAM, N.Y., February 15, 2024–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced that it has completed the sale of its PICC and Midline […]
Life Line Screening, Nationwide Cardiovascular Health & Stroke Risk Screening Company, Announces Amanda Rangel as Senior Vice President of Global Business Solutions
AUSTIN, Texas–(BUSINESS WIRE)–Life Line Screening, the nation’s leading provider of mobile preventive health screenings for cardiovascular disease and stroke risk is pleased to announce the appointment of Amanda Rangel as Senior Vice President of Global Business Solutions. With her rich background in fostering corporate relationships, Amanda’s expertise will be instrumental as Life Line Screening broadens its commercial outreach. Amanda Rangel comments on her new role: “I’m thrilled to join L
50+ Email Marketing Statistics for 2024: Key Insights & Trends
by CodeinWP Editorial / February 12, 2024 / ideas & inspiration 50+ Email Marketing Statistics for 2024: Key Insights & Trends What’s the ROI for email marketing? Which industries have the highest conversion rates in their email marketing campaigns? How does personalization impact the effectiveness of email marketing? This email […]
30+ Internet Usage Statistics for 2024: Users, Speed, Behavior
by CodeinWP Editorial / February 12, 2024 / ideas & inspiration 30+ Internet Usage Statistics for 2024: Users, Speed, Behavior Despite being relatively new, internet technology has already revolutionized several industries and changed the way we live. With more than five billion users worldwide, internet adoption is growing, especially among […]
RapidAI Announces Late-Breaking Abstract Simultaneously Published in NEJM; Highlights Key Data Revealed at ISC 2024
SAN MATEO, Calif.–(BUSINESS WIRE)–RapidAI, the global leader in developing Artificial Intelligence (AI) and clinical workflow solutions to combat life-threatening neurovascular, cardiac, and vascular diseases, today announced the publication of the TIMELESS trial in the New England Journal of Medicine (NEJM). Other select data from research studies unveiled last week at the […]
Canary Completes First-in-Human Trial of Cardiac Auscultation Monitoring Sensor
The Cardiac Auscultation monitoring device was trialed for use with heart failure patients as an adjunct to care in monitoring the effectiveness of congestive heart failure medication management The limited clinical trial represents the first human implantation of a cardiac auscultation sensor device Heart failure affects one in five people, […]



